Business Wire11.20.17
CONMED Corporation announced that Luke A. Pomilio, executive vice president, finance, and chief financial officer (CFO), has decided to retire after over two decades of service with the company.
CONMED has initiated a search for a new CFO. In order to ensure an orderly transition, Pomilio is committed to remaining in his current role until a successor is found.
Curt R. Hartman, CONMED’s president and CEO, said, “On behalf of the Board and the entire CONMED team, I would like to thank Luke for his contributions to the improvement of the company’s commercial execution, to the development of our financial organization, and to CONMED as a whole. We appreciate his commitment to our company and its shareholders during his career here, and we wish him the very best as he transitions into retirement.”
“I have been honored to be a part of the CONMED team for the last two decades and to lead its finance team for the past several years. I am proud of the progress we have made in strengthening the Company’s profile, and I am confident that CONMED is well positioned for growth and success,” Pomilio said.
Pomilio was appointed CONMED’s CFO on April 1, 2015. He joined the company as controller in September 1995 and, subsequently, assumed additional responsibilities for certain corporate functions including worldwide operations and select administrative functions. In May 2009, he was promoted to vice president, controller and corporate general manager. Prior to joining CONMED, Pomilio was employed as a manager with Price Waterhouse LLP.
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. CONMED has a direct selling presence in 17 countries, and international sales constitute approximately 50 percent of the company’s total sales. Headquartered in Utica, N.Y., the company employs approximately 3,300 people.
CONMED has initiated a search for a new CFO. In order to ensure an orderly transition, Pomilio is committed to remaining in his current role until a successor is found.
Curt R. Hartman, CONMED’s president and CEO, said, “On behalf of the Board and the entire CONMED team, I would like to thank Luke for his contributions to the improvement of the company’s commercial execution, to the development of our financial organization, and to CONMED as a whole. We appreciate his commitment to our company and its shareholders during his career here, and we wish him the very best as he transitions into retirement.”
“I have been honored to be a part of the CONMED team for the last two decades and to lead its finance team for the past several years. I am proud of the progress we have made in strengthening the Company’s profile, and I am confident that CONMED is well positioned for growth and success,” Pomilio said.
Pomilio was appointed CONMED’s CFO on April 1, 2015. He joined the company as controller in September 1995 and, subsequently, assumed additional responsibilities for certain corporate functions including worldwide operations and select administrative functions. In May 2009, he was promoted to vice president, controller and corporate general manager. Prior to joining CONMED, Pomilio was employed as a manager with Price Waterhouse LLP.
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. CONMED has a direct selling presence in 17 countries, and international sales constitute approximately 50 percent of the company’s total sales. Headquartered in Utica, N.Y., the company employs approximately 3,300 people.